Anxiety & Addiction

What anxiety disorders actually look like in adults

Anxiety is not simply stress or nervousness. The DSM-5 identifies a family of distinct anxiety disorders, each with its own clinical profile, but all characterized by excessive fear or worry that is disproportionate to the actual situation and that significantly impairs daily functioning. Generalized anxiety disorder (GAD) involves persistent, difficult-to-control worry across multiple life domains, accompanied by physical symptoms including muscle tension, fatigue, irritability, and sleep disturbance. Panic disorder produces recurrent, unexpected panic attacks, intense surges of fear with physical symptoms such as racing heart, shortness of breath, chest pain, dizziness, and derealization, followed by persistent worry about future attacks and behavioral avoidance.

Social anxiety disorder is characterized by intense fear of scrutiny or humiliation in social or performance situations. Agoraphobia involves fear and avoidance of situations where escape might be difficult or help unavailable. Specific phobias produce marked fear of circumscribed objects or situations. In clinical practice, most people with anxiety disorders present with features of more than one type, and trauma-related anxiety, including PTSD and acute stress disorder, frequently overlaps with other anxiety presentations. The GAD-7, administered at intake, provides a standardized severity score our team uses to track symptom trajectory throughout treatment.

In the United States, anxiety disorders are the most prevalent mental health condition, with lifetime rates exceeding 30 percent of adults according to NIMH epidemiological data. When substance use develops alongside anxiety, it creates a bidirectional reinforcing cycle that typically cannot be broken without addressing both conditions at once.

How anxiety and substance use reinforce each other

The pharmacological relationship between anxiety and substance use runs in both directions. Alcohol, benzodiazepines, and cannabis all have anxiolytic properties in the short term: they reduce activation of the amygdala, slow the nervous system, and provide immediate relief from the subjective experience of anxiety. This is why people with anxiety disorders are at significantly elevated risk of developing alcohol and sedative use disorders. The relief is real, which is what makes these substances so reinforcing.

The problem is neuroadaptation. With repeated use, the brain compensates for the sedating effect of alcohol and benzodiazepines by upregulating its excitatory systems. When the substance is removed, the nervous system is now running hot without the chemical brake, producing a withdrawal syndrome that can be more anxious, more agitated, and more physically intense than the original baseline anxiety. Benzodiazepine withdrawal in particular is one of the medically dangerous withdrawal syndromes because of its risk of seizures and severe anxiety rebound.

Stimulant use, paradoxically common in people with anxiety who self-medicate fatigue or depression, produces direct activation of the stress response and can trigger or mimic panic attacks. Opioid withdrawal produces a hyperadrenergic state marked by anxiety, insomnia, and irritability. Whatever the substance, the withdrawal phase reliably worsens anxiety, and the subsequent craving is partly driven by the desire to quiet that withdrawal-induced anxiety. This is the cycle integrated treatment is designed to interrupt.

Why integrated treatment is the clinical standard

Treating anxiety without treating substance use, or treating substance use without treating anxiety, consistently underperforms integrated care. The untreated condition keeps pulling the client back: unmanaged anxiety drives self-medication, and ongoing substance use keeps the nervous system dysregulated and overwhelmed.

Both NIMH and SAMHSA identify co-occurring mental health and substance use disorders as best treated together, under one coordinated plan, by one clinical team. At The Archangel Centers, this means the same psychiatrist who evaluates your anxiety disorder and considers medication also knows what you are taking in MAT, what your substance use history looks like, and what the therapist is working on in your CBT sessions. There are no referral handoffs, no gaps between providers, and no one telling you to work on sobriety before you can address the anxiety that has been driving use for years.

Our integrated model follows the same standard of care that the evidence base supports: simultaneous, not sequential. SAMHSA's TIP 42 guidance on co-occurring disorders identifies integrated treatment as producing higher rates of treatment completion, lower relapse rates, and better long-term functioning than parallel or sequential approaches. That evidence is what drives the clinical structure at The Archangel Centers.

Clinical modalities used to treat anxiety and addiction together

Each therapeutic tool in our dual-diagnosis model addresses a specific mechanism of the co-occurring presentation.

• Cognitive behavioral therapy (CBT): identifies and reframes the catastrophic and avoidance-driven thought patterns that maintain both anxiety disorders and substance use, including exposure-based techniques for panic disorder, social anxiety, and specific phobias
• Dialectical behavior therapy (DBT): builds distress tolerance and emotional regulation skills that reduce the urge to self-medicate anxiety with substances
• Exposure and response prevention (ERP): systematic, graduated exposure to anxiety-provoking situations with response prevention (not using substances) to break the avoidance cycle
• Mindfulness-based stress reduction (MBSR) and grounding: portable techniques to calm the nervous system in real time without substances
• Motivational interviewing: addresses ambivalence about giving up substances that have provided genuine relief, building intrinsic motivation for change
• Trauma-informed care with EMDR: available in individual therapy when anxiety is rooted in traumatic experiences
• Psychiatric medication management: SSRIs and SNRIs are first-line pharmacological options for most anxiety disorders and are non-addictive, making them safe for people with substance use histories; prescribing of benzodiazepines is approached with significant caution given their abuse potential
• GAD-7 and PHQ-9 monitoring: standardized tracking at intake and throughout treatment to measure symptom trajectory objectively and guide clinical adjustments
• Safety planning: completed on admission day and revisited throughout, addressing warning signs, coping strategies, and crisis resources
• Family programming: sessions led by Lauren Sorrentino at both locations, available under signed release

What treatment looks like day to day across levels of care

Admission day at The Archangel Centers includes a full clinical assessment with your primary therapist, an intake with the on-site medical provider, and completion of a standardized assessment battery: ASAM criteria, LOCUS mental health acuity, PHQ-9, GAD-7, Columbia Suicide Severity Rating Scale, and biopsychosocial screening. If your anxiety or withdrawal symptoms exceed the scope of outpatient care, the team coordinates appropriate placement before programming begins and supports your transition back when you are stable.

The skill-building phase involves CBT exposure work, cognitive restructuring, DBT group skills, relaxation training, relapse prevention planning, and trauma-informed group programming. The medical provider monitors panic frequency, avoidance behaviors, sleep quality, and any ideation at regular intervals and adjusts the medication plan as your clinical picture evolves. Progress is objective: GAD-7 and PHQ-9 scores provide a consistent trend line.

As treatment progresses, the focus shifts to applying learned skills in real environments, extending exposure practices outside sessions, and preparing a discharge plan that addresses both anxiety relapse and substance-use relapse. Aftercare coordination connects clients to outpatient continuing care, alumni community involvement, and outside providers before leaving any higher level of care.

Levels of care for co-occurring anxiety: Partial Care, IOP, and outpatient

Severe, disabling anxiety paired with active substance use often needs the daily structure and clinical density of Partial Hospitalization (Partial Care). Our Tinton Falls, New Jersey clinic runs Partial Care six days per week, Monday through Saturday. Our Charlotte, North Carolina clinic runs PHP five days per week, Monday through Friday. Both are full-day programs for adults whose anxiety and substance use have significantly impaired their ability to function, including those with severe avoidance, frequent panic attacks, or safety concerns that do not require inpatient hospitalization.

Intensive Outpatient is available at both locations on a schedule of three or five days per week for three-hour sessions. IOP is the most compatible level of care with maintaining employment and is also the appropriate step-down from Partial Care as symptoms stabilize. Standard outpatient continuing care follows, providing ongoing individual therapy, periodic medical follow-up, and group access as needed.

Virtual treatment is available to New Jersey residents, allowing IOP or outpatient participation by secure video for clients who cannot commute to Tinton Falls. Benzodiazepine withdrawal can be medically dangerous, and if a client needs supervised medical detox before entering outpatient treatment, our team coordinates that placement and plans the transition into our program. We do not provide detox or inpatient care ourselves, but we ensure there are no gaps in the clinical handoff.

Insurance, cost, and getting started

Most major commercial insurance plans cover medically necessary dual-diagnosis outpatient treatment under the Mental Health Parity and Addiction Equity Act (MHPAEA). The Archangel Centers is in-network with Aetna, Cigna, BlueCross BlueShield, United Healthcare, Horizon BCBS, AmeriHealth NJ, Humana, and Tricare. Our admissions team verifies your benefits for free before any commitment, typically within the first call, so your real out-of-pocket costs are clear before you make any decision.

Admissions is confidential, 24 hours a day, seven days a week. Calling (888) 464-2144 connects you to a specialist who can run the benefit check, discuss levels of care, and often arrange same-week placement. No prior referral is needed. The clinical team determines the appropriate level of care based on the initial assessment, not before it. Sliding scale and payment plan options are available for clients whose coverage is limited.